アテゾリズマブ (Japanese Wikipedia)
Analysis of information sources in references of the Wikipedia article "アテゾリズマブ" in Japanese language version.
refsWebsite
Global rank
Japanese rank
3,823rd place
low place
low place
low place
6,690th place
394th place
5th place
19th place
1,010th place
4,166th place
creativecommons.org
- Nasser, Nicola J.; Gorenberg, Miguel; Agbarya, Abed (November 2020). “First line Immunotherapy for Non-Small Cell Lung Cancer” (英語). Pharmaceuticals 13 (11): 373. doi:10.3390/ph13110373. PMC 7695295. PMID 33171686.
Text was copied from this source, which is available under a Creative Commons Attribution 4.0 International License.
doi.org
- Nasser, Nicola J.; Gorenberg, Miguel; Agbarya, Abed (2020-11-08). “First line Immunotherapy for Non-Small Cell Lung Cancer” (英語). Pharmaceuticals 13 (11): 373. doi:10.3390/ph13110373. ISSN 1424-8247. PMC 7695295. PMID 33171686.
- Nasser, Nicola J.; Gorenberg, Miguel; Agbarya, Abed (November 2020). “First line Immunotherapy for Non-Small Cell Lung Cancer” (英語). Pharmaceuticals 13 (11): 373. doi:10.3390/ph13110373. PMC 7695295. PMID 33171686. Text was copied from this source, which is available under a Creative Commons Attribution 4.0 International License.
- “De-novo and acquired resistance to immune checkpoint targeting”. The Lancet. Oncology 18 (12): e731–e741. (December 2017). doi:10.1016/s1470-2045(17)30607-1. PMID 29208439.
europa.eu
ema.europa.eu
- “Tecentriq EPAR”. European Medicines Agency. 2020年7月31日閲覧。 Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
immuno-oncologynews.com
mdpi.com
- Nasser, Nicola J.; Gorenberg, Miguel; Agbarya, Abed (2020-11-08). “First line Immunotherapy for Non-Small Cell Lung Cancer” (英語). Pharmaceuticals 13 (11): 373. doi:10.3390/ph13110373. ISSN 1424-8247. PMC 7695295. PMID 33171686.
- Nasser, Nicola J.; Gorenberg, Miguel; Agbarya, Abed (November 2020). “First line Immunotherapy for Non-Small Cell Lung Cancer” (英語). Pharmaceuticals 13 (11): 373. doi:10.3390/ph13110373. PMC 7695295. PMID 33171686. Text was copied from this source, which is available under a Creative Commons Attribution 4.0 International License.
medicines.org.uk
nih.gov
pubmed.ncbi.nlm.nih.gov
- Nasser, Nicola J.; Gorenberg, Miguel; Agbarya, Abed (2020-11-08). “First line Immunotherapy for Non-Small Cell Lung Cancer” (英語). Pharmaceuticals 13 (11): 373. doi:10.3390/ph13110373. ISSN 1424-8247. PMC 7695295. PMID 33171686.
- Nasser, Nicola J.; Gorenberg, Miguel; Agbarya, Abed (November 2020). “First line Immunotherapy for Non-Small Cell Lung Cancer” (英語). Pharmaceuticals 13 (11): 373. doi:10.3390/ph13110373. PMC 7695295. PMID 33171686. Text was copied from this source, which is available under a Creative Commons Attribution 4.0 International License.
- “De-novo and acquired resistance to immune checkpoint targeting”. The Lancet. Oncology 18 (12): e731–e741. (December 2017). doi:10.1016/s1470-2045(17)30607-1. PMID 29208439.
ncbi.nlm.nih.gov
- Nasser, Nicola J.; Gorenberg, Miguel; Agbarya, Abed (2020-11-08). “First line Immunotherapy for Non-Small Cell Lung Cancer” (英語). Pharmaceuticals 13 (11): 373. doi:10.3390/ph13110373. ISSN 1424-8247. PMC 7695295. PMID 33171686.
- Nasser, Nicola J.; Gorenberg, Miguel; Agbarya, Abed (November 2020). “First line Immunotherapy for Non-Small Cell Lung Cancer” (英語). Pharmaceuticals 13 (11): 373. doi:10.3390/ph13110373. PMC 7695295. PMID 33171686. Text was copied from this source, which is available under a Creative Commons Attribution 4.0 International License.
dailymed.nlm.nih.gov
- “Tecentriq- atezolizumab injection, solution”. DailyMed (2020年6月3日). 2020年7月31日閲覧。
pmda.go.jp
info.pmda.go.jp
- “テセントリク点滴静注840mg／テセントリク点滴静注1200mg 添付文書”. www.info.pmda.go.jp. PMDA. 2021年5月28日閲覧。
worldcat.org
search.worldcat.org
- Nasser, Nicola J.; Gorenberg, Miguel; Agbarya, Abed (2020-11-08). “First line Immunotherapy for Non-Small Cell Lung Cancer” (英語). Pharmaceuticals 13 (11): 373. doi:10.3390/ph13110373. ISSN 1424-8247. PMC 7695295. PMID 33171686.